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Abstract
With rapid development of novel nanotechnologies that incorporate engineered nanomaterials 
(ENMs) into manufactured products, long-term, low dose ENM exposures in occupational settings 
is forecasted to occur with potential adverse outcomes to human health. Few ENM human health 
risk assessment efforts have evaluated tumorigenic potential of ENMs. Two widely used nano-
scaled metal oxides (NMOs), cerium oxide (nCeO2) and ferric oxide (nFe2O3) were screened in 
the current study using a sub-chronic exposure to human primary small airway epithelial cells 
(pSAECs). Multi-walled carbon nanotubes (MWCNT), a known ENM tumor promoter, was used 
as a positive control. Advanced dosimetry modeling was employed to ascertain delivered vs. 
administered dose in all experimental conditions. Cells were continuously exposed in vitro to 
deposited doses of 0.18 μg/cm2 or 0.06 μg/cm2 of each NMO or MWCNT, respectively, over 6 and 
10 weeks, while saline- and dispersant-only exposed cells served as passage controls. Cells were 
evaluated for changes in several cancer hallmarks, as evidence for neoplastic transformation. At 10 
weeks, nFe2O3- and MWCNT-exposed cells displayed a neoplastic-like transformation phenotype 
with significant increased proliferation, invasion and soft agar colony formation ability compared 
to controls. nCeO2-exposed cells showed increased proliferative capacity only. Isolated nFe2O3 
and MWCNT clones from soft agar colonies retained their respective neoplastic-like phenotypes. 
Interestingly, nFe2O3-exposed cells, but not MWCNT cells, exhibited immortalization and 
retention of the neoplastic phenotype after repeated passaging (12 – 30 passages) and after 
cryofreeze and thawing. High content screening and protein expression analyses in acute exposure 
ENM studies vs. immortalized nFe2O3 cells, and isolated ENM clones, suggested that long-term 
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exposure to the tested ENMs resulted in iron homeostasis disruption, an increased labile ferrous 
iron pool, and subsequent reactive oxygen species generation, a well-established tumorigenesis 
promotor. In conclusion, sub-chronic exposure to human pSAECs with a cancer hallmark 
screening battery identified nFe2O3 as possessing neoplastic-like transformation ability, thus 
suggesting that further tumorigenic assessment is needed.
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1. Introduction
Incorporation of engineered nanomaterials (ENMs) into nanotechnology applications has 
reached far across numerous fields including industry, household products, commerce, and 
healthcare [1,2]. For example, current estimates place the nanotechnology industry with 6 
million workers and a projected $3 trillion value by 2020 [3]. Along with the numerous 
benefits from nanotechnology development, concern about potential adverse effects to 
human and environmental health have arisen [4]. ENMs possess unique physicochemical 
properties, such as high surface-to-volume ratio, which impart unique, but somewhat 
unpredictable effects once exposed to biological systems. Several inhaled ENMs, including 
MWCNT, show unique toxicokinetics, biopersistence, and adverse effects inclusive of 
epigenetic alterations in exposed lung and extrapulmonary tissues in animal models [5–7]. 
With such large scale ENM production potential in the near future, long-term exposures to 
ENMs in the workplace are likely to occur [8], however, minimal information is available 
for long-term exposures and the potential for ENM exposure-associated carcinogenesis. 
Stueckle et al. Page 2













Exposure to numerous occupational and urban air contaminants is suspected to initiate, via 
DNA damage, or promote tumorigenesis which alters cell signaling/crosstalk, expands 
damaged cells, and increases cancer hallmark behaviors, ultimately leading to neoplastic 
transformation and formation of an in vivo tumor [9]. Considering most ultrafine particles 
and ENMs deposit deep in the lung following inhalation [4], human primary small airway 
epithelial cells (pSAECs) represent one of the main targets following inspiration of ENMs 
and exhibit DNA damage, ROS, pro-inflammatory and cell damage signaling [10–12], 
which correlate to in vivo models of ENM exposure [13]. With hundreds of new ENM 
products in the market every year, evaluating numerous ENMs for carcinogenesis potential 
is quickly becoming a critical need for occupational risk assessment [14–15].
Few studies have focused on NMO carcinogenic potential. NMOs at nano and sub-micron 
ranges are released in various occupational settings with metal mass median concentrations 
between 0.73–1.47 μg/m3, and even higher concentrations in personal breathing zones (3.3 – 
47.67 μg/m3) during handling activities [16,17]. One report describes silica-iron nanoparticle 
air concentrations up to 46,000 μg/m3 inside a spray enclosure while outside spray enclosure 
concentrations were measured at ≤ 2.6 μg/m3 [18]. Given the abilities of NMOs to penetrate, 
biopersist, damage, and initiate genotoxicity in exposed tissue, the possibility of ENM-
induced or promoted tumorigenesis is a rising concern [14, 19–21].
Consistently, two NMOs with numerous nanotechnology applications, that have received 
increased toxicological testing attention, are nano-scaled cerium dioxide (nCeO2) and ferric 
oxide (nFe2O3); thus, warranting further investigation into their carcinogenic potential. 
Cerium oxide, an oxidized lanthanide metal, is used in a variety of mechanical glass 
polishing applications, cosmetics as a UV absorber, and as a proficient catalyst as a diesel 
fuel additive to aid in emission reduction, which subsequently leads to its release in the 
particulate phase of exhaust [22,23]. While data is somewhat limited regarding the 
occupational exposure concentrations and limits, expected inhalation of nCeO2 from diesel 
engines is estimated at approximately 0.09 μg/kg body weight for 8 h [23]. Thus, total lung 
burden over human working life time would be approximately 936 μg/kg [24]. Using a 10-
fold safety factor, known rat mass, and lung surface area, 0.150 mg/kg – 7 mg/kg per rat or 
0.008 μg/cm2 – 0.35 μg/cm2 alveolar surface area is a reasonable exposure range to assess 
pulmonary toxicity [24]. Cerium induces pneumoconiosis upon occupational exposure and is 
found in human alveoli and pulmonary interstitial tissue for decades post-exposure [22]. 
Mouse and rat in vivo studies reported pulmonary inflammation, lipid peroxidation, and 
fibrosis, as well as the bio-accumulation of nCeO2 following exposure [21, 23, 24–28]. 
Although exposure route-dependent redox status discrepancies exist, nCeO2 has also been 
shown to cause DNA damage and oxidative stress in human dermal fibroblasts and bronchial 
epithelial cells [27, 29, 30]. Past tumorigenesis studies in animal models suggest that 
micron-sized CeO2 exhibits low tumorigenesis risk [31], however, little is known about 
nCeO2 tumorigenesis risk and whether known inflammation, relatively low reactive oxygen 
species (ROS) generation, genotoxicity, and biopersistence contribute to tumor initiation 
and/or promotion.
Iron oxide nanoparticle (IONP) technologies have gained great interest and advancement 
due to its wide availability and its catalytic and paramagnetic properties suited for use in 
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biomedical imaging, paints, ceramics, catalysis, and pigments [32], however, concern over 
their use is warranted [33]. Current iron oxide fume fine particle occupational permissible 
and recommended exposure limit in ambient air over an 8 hour workday is 10 mg/m3 
(OSHA) and 5 mg/m3, respectively (NIOSH). At present, no exposure limit for particle size 
(including nanometer) is proposed for iron oxide. Estimated tissue doses of airborne IONP 
in mice exposed to the current OSHA PEL is 0.003 – 2.2 μg/cm2 in bronchioles and 0.003 – 
0.13 μg/cm2 in alveolar area [20]. Prolonged or high exposure to sub-micron and micron-
sized particulates with bound iron, such as ambient particulate and asbestos, and 
combustion-derived iron oxide induces ROS, inflammation, and pneumoconiosis [34]. In 
addition, iron nanoparticle deposits are found in lung macrophages of welders and are 
thought to contribute to inflammation [35]. Iron is carcinogenic in animal models and 
prolonged elevated iron levels in tissue is widely believed to promote several human cancers, 
including lung cancer [36,37]. Recent iron nanoparticle in vitro epithelial and in vivo lung 
exposures show similar effects, with the addition of DNA fragmentation, inflammation-
induced DNA adducts, hyperplasia, membrane damage, biopersistence and initial signs of 
fibrosis in exposed tissues [6, 20, 38, 39), although other studies show benign effects 
[reviewed by 33]. Given the large benefits of developing cerium and IONP technology and 
the perceived long-term health risks associated with exposure, establishing standardized in 
vitro assays to screen numerous ENMs for tumorigenic potential are urgently needed [15, 
32].
The present work tested cell transformation potential of nCeO2 and nFe2O3 compared to 
albumin-dispersed MWCNT, which served as a positive control particle. MWCNT were 
recently shown to initiate lung carcinogenesis in rats [40], promote tumor formation in mice 
[41], and cause neoplastic-like transformation [10]. In addition, herein we evaluated whether 
pSAECs could serve as a neoplastic transformation model, in addition to traditional 
immortalized cell models, to screen engineered nanomaterials for tumorigenesis risk. Such 
sub-chronic in vitro exposure models help identify complete carcinogens by capturing both 
initiation and promotion in early tumorigenesis [42]. We hypothesized that sub-chronic 
exposure to both nCeO2 and nFe2O3 would cause early cell transformation and retention of 
neoplastic behavior in human pSAECs, similar to MWCNTs. Here, we show that continuous 
nFe2O3 exposure for 10 weeks caused immortalization and enhanced tumor-like phenotype 
in pSAECs, similar to MWCNT-exposed cells, while nCeO2 exposure increased 
proliferation but did not cause immortalization or transformation. Collectively, our results 
demonstrate that prolonged nFe2O3 exposure harbors some tumorigenic potential that should 
be further explored. Additionally, this work suggests that human pSAECs can be used as a 
neoplastic transformation screening model for numerous ENMs for use in tiered risk 
assessment.
2. Methods
A more detailed description of Methods can be found in Appendix A.
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2.1 Characterization of ENMs
nCeO2 and nFe2O3 were manufactured in-house at Harvard University via flame spray 
pyrolysis using the Harvard Versatile Engineered Nanomaterial Generating System 
(VENGES) developed by the authors [43–45]. Specific surface area (SSA; m2/g), was 
determined for powdered ENMs using nitrogen adsorption/Brunauer-Emmett-Teller method 
which was then used to calculate the BET equivalent primary particle size assuming 
spherical particles. MWCNT Mitsui #7 (Hodogaya Chemical) have previously undergone 
thorough characterization [46], and are known to promote lung adenocarcinoma and serosal 
lesions consistent with the diagnosis of sarcomatous mesothelioma in vivo [41]. All 
materials were characterized using x-ray diffraction diameter, density, and FESEM [25, 43–
45].
2.2 ENM Dispersal, Characterization in Suspension, and Dosimetric Considerations for In 
Vitro Testing
Stock solutions of NMOs (0.1 mg/ml) were prepared by dilution of 1 mg/ml stock solutions 
with sterile MilliQ water. NMO solutions were sonicated in water, while 0.1 mg/ml 
MWCNT solutions (1 mg/ml) were sonicated in 1.5% v/v bovine serum albumin (BSA) 
dispersant solution using a SonicCell cup sonicator to achieve uniform dispersion [47]. Each 
dispersed ENM was serially diluted with small airway epithelial cell growth medium 
(SAGM) to the reported concentrations and characterized for intensity-weighted 
hydrodynamic diameter (dH), polydispersity index (PdI), zeta potential (ζ), and specific 
conductance (σ) by dynamic light scattering (DLS) following established protocols [48]. 
The recently developed Volumetric Centrifugation Method (VCM) [49] determined to 
measure effective density (ρagg) of the formed agglomerates. Advanced distorted grid (DG) 
fate and transport modeling was conducted to report Relevant In Vitro Dosimetry functions 
as described in Appendix A following published procedures [47, 50, 51].
2.3 ENM Uptake and Cellular Localization
Uptake and localization analysis of ENM in pSAECs (Lonza) was performed using 
enhanced darkfield imaging following a 24 h exposure, as previously described [10]. Briefly, 
pSAECs were seeded onto conditioned coverslips in a 24-well plate, and exposed in 
duplicate to administered doses of either dispersed 0.06 μg/cm2 NMO or 0.06 μg/cm2 
MWCNTs for 24 h. Fixed and stained cells were imaged with an Olympus microscope 
equipped with Cytoviva. Next, ENM intracellular localization was assessed via transmission 
electron microscopy (TEM; JEOL 1220, Tokyo) following exposure to all ENMs (0.6 μg/
cm2) for 24 h using previously described methods [13,24].
2.4 Sub-chronic exposure to primary SAEC
Human pSAEC (Lonza) were seeded in a 25 cm2 flask holding small airway basal medium 
supplemented with Clonetics Growth Supplements (Lonza) and 1% penicillin/streptomycin 
to obtain small airway growth medium (SAGM). Cells were cultured in a humid atmosphere 
at 37°C containing 5% CO2 air with medium changes every 3 days, per manufacturer’s 
instructions. For passaging, all cell cultures were washed in HEPES-buffered saline, 
incubated in one volume of 0.25% Trypsin/EDTA for 5 m, and neutralized in 2 volumes of 
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trypsin neutralization saline following manufacturer’s protocol (Lonza). Unexposed, low 
passage immortalized SAECs (hTERT) were cultured in identical conditions and 
periodically used as a comparative control.
To initiate exposure, pSAECs were seeded (5×104/well) overnight in triplicate to tissue 
culture treated 6-well plates (BD Falcon). Following seeding, cells were continuously 
exposed to administered doses of 0.6 μg/cm2 dispersed nCeO2, or nFe2O3, or 0.06 μg/cm2 
MWCNT twice a week for up to 12 weeks, as previously described with modifications [10]. 
Briefly, NMO administered doses were based on estimated worst case exposure scenarios 
and/or documented upper limit exposure levels. The nCeO2 dose, calculated by deposited 
mass per rat lung surface area, reflected a worst-case exposure (~10 mg/kg) over a working 
lifetime exposure to nCeO2-containing diesel exhaust and was shown to induce 
inflammation, lung damage, and onset of lung fibrosis in exposed rat lung [24]. Likewise, 
the nFe2O3 dose (0.6 μg/cm2) represents deposited dosimetry for IONPs at the current 
OSHA permissible exposure limit (PEL) [20]. The MWCNT dose reflected a reasonable 
occupational exposure with an expected deposited dose in a 30 μg/mouse model, known to 
cause chromosome aneuploidy, mirrored a CNT lung burden known to promote lung cancer, 
and results in neoplastic-like transformation in human SAECs [10,41]. Cells were rinsed 
once in ENM-free warm growth medium and re-exposed every three days, and passaged 
every ~6 – 9 days throughout the experiment. Exposed cells were passage matched to saline 
and dispersant-only cells throughout experiment.
2.5 Cancer Hallmark Assessment
Sub-chronic exposed cells were assayed at 6 and 10 weeks of exposure duration for several 
cancer cell hallmark behaviors including WST-1 cell proliferation, Transwell invasion, soft 
agar colony formation, and morphological transformation using previously described 
standardized methods with minor modifications [10]. More detail can be found in Appendix 
A.
2.7 Clonal Expansion and Cancer Hallmark Assessment
To further evaluate neoplastic transformation in ENM-exposed pSAECs, 10 to 12 soft agar 
colonies were removed from 10 week exposed treatments, and re-established in culture for 
cancer hallmark evaluation as described above and in Appendix A. Briefly, a small core of 
agar containing each colony was removed from suspension, transferred to 48-well plates, 
cultured in SAGM, and expanded in 6-well plates to acquire colony clones for hallmark 
screening and protein expression analyses.
nFe2O3 and MWCNT clones were evaluated for retention of the enhanced cell proliferation, 
invasion, and soft agar colony formation, as previously described, compared to saline-, 
albumin-, and 10 week-exposed cells. Saline and albumin-exposed cells were used for both 
proliferation and invasion assays. In addition, apoptosis resistance via either the intrinsic or 
extrinsic pathway was evaluated by conducting dose-response studies using tumor necrosis 
factor alpha (TNF-α) and FAS ligand (FasL). Since saline and albumin-treated cells 
underwent senescence after 12 weeks in culture, low passage pSAECs were used as 
appropriate negative controls for a normal epithelial cell phenotype in the apoptotic 
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resistance assay. Briefly, cells exposed to nFe2O3 for 10 weeks, nFe2O3 clones, and 
MWCNT clones (1 ×104) exposed to 0 – 50 ng/ml TNF-α, 0 – 30 μM antimycin-α, and 0 – 
50 ng/ml FasL for 24 h according to previously described methods [52]. Next, cells were 
stained with a Hoescht 33342 and propidium iodide (PI) fluorescent dye cocktail, imaged 
with the ImageXpress Micro XLS system (IMX; Molecular Devices, LLC) to quantitatively 
score live, apoptotic and necrotic cells. Data were exported to Excel for further statistical 
analysis.
2.8 Live cell and ROS generation quantification following acute exposure
pSAECs (5×103) were seeded into each well of a 96-well plate overnight and then exposed 
to administered doses ranging 0 – 2 μg/cm2 of each NMO for 24 and 48 h in sextuplet. Live 
and dead cells were stained with 1 μM Hoescht 33342 and 10 μg/ml PI and imaged at 4X 
magnification on the IMX system. To determine ROS generation potential of NMO 
exposure, cells (5 ×103) were plated in triplicate in a 96-well plate and exposed to each 
NMO and MWCNT for 1 – 48 h. Following exposure, cells were stained with either 
MitoSox Red (Molecular Probes) or 2′,7′-dichlorofluorescin diacetate (DCF; Sigma 
Aldrich), and Hoescht 33342 (Invitrogen) for 30 minutes, washed twice with fresh medium, 
and subsequently imaged at 10X magnification with the IMX system. MitoSox Red and 
DCF stain intensity was determined and exported as previously described above.
2.9 Western Blot analysis of key proteins for iron homeostasis
SAEC-hTERTs (5 ×105 cells) were plated in the wells of a 6-well plate overnight then 
exposed to an ENM particle-containing medium for 24 or 48 h. Sub-chronic exposed cells 
and low passage pSAECs were plated at the same density and cultured for either 24 or 48 h. 
Protein was isolated from all cells following previously described methods [10]. Equal mass 
of isolated protein were separated by 10% bis-Tris acrylamide gels and transferred to 
nitrocellulose membranes. Membranes were probed with primary CD71, FTH1, GAPDH 
(Cell Signaling) and SCL40A1 (Abcam) DMT1 (Abcam) antibodies, incubated with 
secondary anti-rabbit or anti-mouse (Santa Cruz Biotechnology) HRP-conjugated antibody, 
and incubated in chemiluminescent substrate for X-ray film detection. Densitometry was 
performed on protein bands using ImageJ software (NIH).
2.10 Intracellular iron assessment
SAEC-hTERTs (2 ×106) were plated in triplicate to 10 cm2 culture plates and exposed to 
administered doses of either 0, 0.06, or 0.6 μg/cm2 of each ENM for 48 h. SAEC-hTERT 
were used since obtaining enough low passage pSAEC to assess iron levels was not feasible. 
Following exposure, intracellular iron was assessed using the Iron Assay kit according to the 
manufacturer’s instructions (Sigma Aldrich). Low passage, unexposed pSAECs and sub-
chronic-exposed pSAECs were also assessed for iron content. Samples with equal mass 
ENM without cells were used as particle controls. Briefly, supernatants from lysed cells 
were split in half to two aliquots, diluted 1:1 v/v with assay buffer, and added in triplicate to 
a 96-well plate. Iron reducing reagent was added to one aliquot while equal volume of buffer 
was added to the other aliquot to determine total and ferrous iron (Fe2+), respectively. Lastly, 
samples were incubated with an iron probe and absorbance assayed at 593 nm. Absorbance 
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values were corrected from background and PBS buffer controls, then normalized for live 
cell count (2×106) due to ENM toxicity at 6 μg/cm2 in some treatments.
2.11 Statistical Analysis
All datasets were imported into SAS JMP v.10 and analyzed for normal distribution of 
residuals and variance homogeneity using goodness of fit tests and Bartlett’s test. Data were 
log-transformed to achieve normal distributions. Treatments were compared using one- or 
two-way ANOVA followed by Dunnett’s or Tukey-Kramer HSD post-hoc tests (α = 0.05). 
For those data lacking equal variance, the Kruskal-Wallis test using χ2 statistic was used to 
compare treatments.
3. Results
3.1 Characterization of ENMs
Table 1 summarizes the characterization of the dry ENM powders used in the study, 
including specific surface area and primary particle diameters. nCeO2 was previously 
described as loose agglomerates with fractal structure following VENGES synthesis as 
determined by TEM [25]. Similarly, nFe2O3 [45] existed as aggregates/agglomerates with 
smaller primary particles. nCeO2 primary particle crystal size was 2-fold larger (dXRD) than 
nFe2O3. MWCNTs, previously characterized [46], possessed typical high-aspect ratio fiber 
characteristics. nFe2O3 primary particles possessed greater surface area (96 m2/g) than 
nCeO2 (59 m2/g) and MWCNTs (26 m2/g).
Table 2 describes the properties of the tested ENMs suspended in SAGM. Although nCeO2 
exhibited 10-fold larger agglomerate dH than nFe2O3 in water, nCeO2 and nFe2O3 had a 
similar volume-weighted dH of 341 nm in SAGM, and displayed a polydispersity index 
(PdI) of 0.401 (nCeO2) and 0.271 (nFe2O3), which is representative of a fairly 
monodispersed suspension. Comparable zeta potential and conductivity measurements were 
also observed in the NMO suspensions of approximately −11 mV and conductivities ranging 
from 8.76 to 11.10 mS/cm. nFe2O3 and MWCNTs exhibited strong positive surface charge 
in water, which switched to minimal negative charge in SAGM medium. nCeO2 showed 
minimal change between water or media suspensions.
3.2 Dosimetric Considerations For In Vitro Testing
The delivered cell dose at a given exposure time point may not always be the same as the 
dose administered [47] due to the differential settling rate of the formed agglomerates in 
vitro. This is defined by two fundamental parameters, the hydrodynamic diameter, dH, of the 
formed agglomerate and its effective density, ρagg [47,49]. Using the recently developed 
Harvard in vitro dosimetry methodology [47, 51], the fraction of the administered particles 
that deposit on the cells located at the bottom of the treatment well as a function of time was 
calculated (Figure 1A). The deposition fraction constants (α1 and α2) as well as the RID 
functions for both NMO particle suspensions are presented (Table 3) for both of the 
experimental conditions used in the study. The nCeO2 and nFe2O3 deposited at a similar 
rate, with an approximate fraction deposited of 0.3 when suspended in SAGM for 48–72 
hours for the sub-chronic (left panel) and acute (right panel) exposure studies. Thus, both 
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administered dose and deposited dose were calculated and reported for the remainder of the 
study.
3.3 NMO uptake
Exposure of nCeO2 or nFe2O3 for 48 h resulted in co-localization of each NMO within 
pSAEC cytoplasm (Figure 1B) with occasional perinuclear localization (Figure B.1). 
Minimal nuclear co-localization of the NMOs was observed. To further assess NMO cellular 
fate in exposed cells, TEM analysis following 24 h exposure revealed evidence for pSAEC 
ENM phagocytosis (Figure 1C–E). Podia-like projections were observed surrounding loose 
agglomerates of both nCeO2 and nFe2O3 (Figure 1C). Close examination of the cell 
periphery and cytoplasm found that nCeO2 was present both in membrane-enclosed vesicles 
and free suspension in cytoplasm. Loose agglomerates of nFe2O3 were exclusively found in 
membrane-bound vesicles (Figure 1D and E). Using enhanced darkfield imaging, MWCNTs 
co-localized with the plasma membrane, cytoplasm, and nucleus (Figure B.1A) of the 
pSAECs. Fine focus adjustment during imaging suggested that MWCNTs had punctured 
both cell and nuclear membranes. In TEM analysis, MWCNTs were observed undergoing 
phagocytosis, piercing cell plasma membranes, or piercing membrane-bound vesicle (Figure 
B.2).
3.4 Cancer Hallmark Assessment
During sub-chronic exposure, all exposed pSAECs were observed to occasionally change 
shape, following trypsinization, passaging, and reseeding, from a cuboidal appearance to a 
more fibroblast-like appearance. As cultures reached greater than 60–70% confluence, 
pSAECs would take on a more cuboidal shape, thus suggesting pSAECs were undergoing 
transient wound healing response under epithelial-mesenchymal transition (EMT) and 
mesenchymal-epithelial transition (MET) cell signaling [53]. Following continuous 6 and 10 
week exposures, sub-confluent NMO- or MWCNT-exposed pSAECs possessed an altered 
cell morphology characterized by a more rounded cell body with some podia (Figure 2A). 
This contrasted with both saline (NMO vehicle) and albumin dispersant (MWCNT vehicle) 
passaged cells that possessed a more elongated cell body under sub-confluent conditions. No 
gross abnormal nuclei (i.e. bi-or multinuclear) cell bodies were observed.
Following 6 weeks of exposure, nCeO2- and MWCNT-exposed cells exhibited significantly 
greater cell proliferation ability, 1.3- to 1.6-fold increase, than saline and albumin passage 
controls (Figure 2B, p ≤ 0.05), as assessed by WST-1 assay. Conversely, nFe2O3-exposed 
cells experienced significant reduction (~40%) in proliferation compared to saline controls 
(p<0.05). All cell types did not show a difference between 24 and 48 h time point possibly 
due to low proliferation rate and attachment-associated behaviors post-seeding.
At 10 week exposure, cells were assayed at 48 and 72 h post-exposure to better assess 
proliferation ability of the culture. Exposure of pSAECs to different NMOs affected cell 
proliferation in a time dependent manner (Figure 2C, p ≤ 0.05). Specifically, nCeO2 and 
nFe2O3 cells experienced significant 4- to 13-fold increases in cell proliferation at 48 h, 
respectively, compared to saline passage control cells. nFe2O3 cell proliferation at 72 h was 
significantly greater than nCeO2 cells. In contrast, MWCNT-exposed cells exhibited a 
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significant, but minimal (1.1-fold, p ≤ 0.05), increase in cell proliferation compared to 
albumin-only passage controls, while albumin passaged cells possessed significant enhanced 
proliferation compared to saline passage control. Following an 8-day recovery post-
exposure, 10 week saline passage control cells showed a significant 5-fold reduction in 
proliferation compared to 6 week saline control cells, suggesting that 10 week cells started 
to exhibit pre-senescent growth (Figure 2D). This was confirmed one week later with 
cessation of cell growth in 11 week old saline control cultures (data not shown). In the 
absence of NMO particles, 10 week old pSAECs displayed a 2- to 2.5-fold reduction in 
proliferation ability at 48 h, but remained significantly higher than saline passaged controls. 
Conversely, MWCNT exposed pSAECs exhibited a striking significant reduction in 
proliferation ability compared to albumin passage control cells (Figure 2D; p ≤ 0.05). 
Similar to saline passage control cells, albumin-only and nCeO2 exposed cells experienced 
senescence at 11 – 12 weeks in culture (1–2 weeks post-10 week exposure; data not shown). 
Conversely, 10 week-exposed nFe2O3 cells remained viable and retained proliferation ability 
well past 12 weeks in culture. In summary, these results indicated that nCeO2 and MWCNT 
exposure caused transient cell hyperplasia in pSAEC. In addition, the proliferative effects of 
nFe2O3 exposure were better retained in recovery than MWCNT-exposed cells.
To assess potential aggressive behavior in NMO- and MWCNT-exposed pSAECs, cells were 
evaluated for chemotactic invasion ability in Matrigel coated transwell inserts. Since 10 
week old primary cultures exhibited signs of pre-senescence, SAEC-hTERTs were used as 
an additional comparative control. Both SAEC-hTERT and nCeO2-exposed pSAECs 
possessed significant enhanced invasion ability compared to saline passage control (Figure 
B.3, p ≤ 0.05). Strikingly, nFe2O3 cells exhibited a significant 21-fold and 3.7-fold increase 
in invasion ability compared to saline and nCeO2-exposed cells, respectively (p ≤ 0.05). 
MWCNT-exposed cells exhibited a minimal but significant increase in invasion compared to 
albumin control (p ≤ 0.05).
The ability of exposed pSAECs to undergo attachment-independent growth and colony 
formation was assessed using soft agar colony formation assay. At 6 weeks, only 12 and 17 
colonies total were found in nFe2O3 and MWCNT plates, respectively (Figure 3A and B). At 
10 weeks, all ENM-exposed cells exhibited significant increases in colony formation 
compared to 6 week cells, saline, and albumin passage controls. nFe2O3- and MWCNT-
exposed cells exhibited a 11- and 5-fold significant enhanced colony formation ability 
compared to nCeO2 cells, respectively (Figure 3B). No colonies were found in saline or 
albumin passage controls at either time point.
Morphological transformation assessment typically relies on two assays, colony forming 
efficiency (cytotoxicity) and cell transformation (invasive Type III foci on a confluent 
monolayer), with malignantly transformed cells showing elevated levels in both assays 
[54,55]. Our data found that attached colony formation ability was dependent on the type of 
ENM particle and exposure time (Figure 3C, p ≤ 0.05). nFe2O3- and MWCNT-exposed 
pSAECs exhibited similar significant increased colony formation ability following 6 and 10 
week exposure (p ≤ 0.05). Surprisingly, nCeO2-exposed cells after 6 and 10 week exposure 
failed to form viable proliferating colonies, possibly due to low survival ability at low 
seeding density and absence of nCeO2 particle stimulatory effect. Saline and albumin 
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control cells showed minimal or no survival ability at low density seeding at either time 
point.
At 6 weeks, nFe2O3- and MWCNT-exposed pSAECs exhibited weak to moderate 
morphological transformation qualitative phenotypes. Each cell type exhibited numerous 
Type I foci in confluent plates with the presence of cells containing abnormal nuclear 
morphology (Figure 3D). Only cells exposed to nFe2O3 developed several Type II foci, with 
surrounding bi-nucleated cells observed (Figure 3D). In MWCNT-exposed cells, large 
polynucleated ‘giant cells’ ranging from 150 – 500 μm in diameter were observed (Figure 
3D and Figure B.4). At 10 weeks, only occasional Type I foci were found in nFe2O3 and 
MWCNT cells with rare occurrence of Type II foci in MWCNT-exposed cells only. nCeO2 
exhibited confluent single cell layers and minimal evidence for morphological 
transformation following 6 week and 10 week exposures.
At two weeks post-10 week exposure, both nFe2O3- and MWCNT-exposed pSAECs 
exhibited retention of enhanced cell proliferation ability compared to controls. At 18 days 
post-exposure (3rd passage post-exposure), one subset of cells were kept in culture while 
aliquots were frozen in liquid nitrogen following the manufacturer’s freezing protocol to 
assess acquisition of immortality. Both fresh and frozen 10 week nFe2O3-exposed cells 
retained proliferation ability for further culturing and were assayed for the remainder of the 
study. Unfrozen nFe2O3 cells were cultured out to 30 passages with no stoppage in 
proliferative culture capacity. Conversely, both fresh and frozen MWCNT-exposed cells only 
survived until 5th and 6th passage post-exposure, respectively, until senescence (data not 
shown), possibly due to the absence of MWCNT particle stimulatory effect (Figure 2) and 
its known ability to damage DNA. 10 week-exposed MWCNT cells were used in clonal cell 
proliferation experiments (described below) prior to senescence. These observations suggest 
that 10 week nFe2O3 exposure to pSAEC resulted in an immortalization-like effect while 
MWCNT exposure did not result in an immortalization effect.
3.5 Colony clone neoplastic behavior
Based on the short life span of pSAEC in culture, and evidence for nFe2O3 and MWCNT 
cell transformation, we isolated and expanded clones from soft agar colonies from each of 
these treatments to further assess transient or persistent cancer cell hallmark phenotypes in 
these transformed cells. Reestablished clones from 10 week-exposed nFe2O3 and MWCNT 
cells experienced >80% survival through the clonal expansion procedure (Figure B.5). 
Surprisingly, nCeO2 colonies placed back into culture arrested growth and underwent cell 
death within 2 weeks of colony collection. No attached nCeO2 colony clones were observed 
on bottom of the well. Furthermore, confluent cultures of nFe2O3 and MWCNT clones, at 2 
passages post-clonal establishment, exhibited foci formation indicating escape from contact 
inhibition signaling and were consistent with Type II foci (Figure 4A and B). Sub-confluent 
nFe2O3 and MWCNT cells exhibited a squamous morphology, while a few cells were 
observed to possess binuclear or polynuclear morphology which was never observed in 
either unexposed or ≤10 week original pSAEC cultures. Cells were re-evaluated at 4 
passages post-clonal isolation resulting in no bi- or poly-nucleated cells were observed (data 
not shown).
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Evaluation of cell proliferation ability revealed that both nFe2O3 and MWCNT colony 
clones exhibited retention of enhanced proliferation compared to 10 week old saline and 
albumin passage controls (Figure 4C). nFe2O3 clones exhibited a significant reduction in 
proliferation ability compared to 10 week immortalized nFe2O3 cells. Interestingly, 
MWCNT clones exhibited equivalent proliferation ability to MWCNT 10 week exposed 
cells. Following nFe2O3 and MWCNT clone proliferation ability, 8 different clones from 
each particle treatment were aliquoted and frozen to evaluate freeze survival ability and 
immortalization. All frozen clones were successful in re-establishing culture and 
proliferation ability following freezing (data not shown). Non-frozen clones were used for 
all subsequent cancer cell hallmark assessments in this study.
Reassessment of soft agar colony forming ability in clones found that nFe2O3 clones 
exhibited significant enhanced (~2.5-fold) soft agar colony forming ability compared to 10 
week-exposed cells (Figure 4D), while MWCNT clones exhibited a minimal, yet significant, 
increase in colony forming ability compared to 10 week cells. Conversely, both nFe2O3 and 
MWCNT clones showed significant reduction (~3-fold) in invasion ability compared to their 
10 week-exposed counterparts (Figure 4E), but still were significantly above both saline and 
albumin passage controls.
Next, we assessed 10 week-exposed nFe2O3 cells, nFe2O3 clones, and MWCNT clones 
resistance to extrinsic and intrinsic apoptosis signaling. Low passage pSAEC exhibited 60% 
viability while nFe2O3 10 week, nFe2O3 clones, and MWCNT clones exhibited >90% 
viability (Figure 4F) without FasL treatment. All cells exhibited a significant, dose-
dependent decrease in viability upon FasL exposure (5 and 50 ng/ml), but ENM-exposed 
cells exhibited a significant increase in viability compared to low passage pSAECs at each 
FasL dose. In addition, 10 week nFe2O3 cells and nFe2O3 clones exhibited significant 
elevation in viability at 50 ng/ml FasL compared to MWCNT clones. These trends indicated 
that ENM exposure caused a basal apoptotic resistance ability in the extrinsic pathway 
compared to parent pSAECs, and that nFe2O3-exposed cells exhibited greater resistance 
than MWCNT clones at high dose. Exposure to TNF-α (0 – 50 ng/ml) or antimycin-a (0–30 
μM) to all cell types resulted in 15–20% increase in apoptosis with no significant difference 
between treatment groups (p > 0.05; data not shown).
3.6 Superoxide radical and ROS generation
Next, nFe2O3 and MWCNT clones were evaluated for potential mechanisms promoting 
pSAEC neoplastic-like transformation and immortalization characteristics. Since ENM 
exposure can result in ROS generation and insoluble particles contribute to disruption of iron 
homeostasis and elevated ROS [34], we conducted acute exposures of both NMOs and 
MWCNTs to pSAECs and SAEC-hTERTs to evaluate these potential effects. nCeO2, 
nFe2O3, and MWCNT exposure (1.8 – 60 ng/cm2 delivered) elicited significant increase in 
superoxide radical generation ability at 1 h compared to saline-only exposed controls 
(Figure 5A, Figure B.6). Similarly, nFe2O3 and MWCNT exposure caused an increase in 
intracellular ROS species at 24 h (Figure 5B and Figure B.7; p ≤ 0.05). Alternatively, 
increasing doses of nCeO2 caused significant reduction of intracellular ROS to pSAEC basal 
levels, suggesting anti-oxidant potential (i.e. 0.168 μg/cm2). Since moderate or high ROS 
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generation can stimulate cell proliferation or cell death pathways, we evaluated acute cell 
proliferation ability. Acute nFe2O3 exposure resulted in significantly elevated cell 
proliferation between 0.006 – 0.177 μg/cm2 delivered, while nCeO2 exposure had no effect 
(Figure B.8). Taken together, moderate exposure to nFe2O3 results in ROS generation and 
stimulation of cell proliferation.
3.7 Iron Assay
To identify potential changes in intracellular iron content which may drive ROS generation 
via the Fenton reaction, SAEC-hTERTs were exposed to 0.018 and 0.18 μg/cm2 delivered of 
each ENM for 48 hours and assayed for intracellular iron. Exposure to nFe2O3 caused a 
significant increase in Fe2+ in lysed cell supernatant (Figure 5C, F=10.4, p = 0.011), while 
nCeO2 and MWCNT exhibited minimal change compared to unexposed cells (p > 0.05). No 
statistical difference in Fe2+ concentration existed between 0.06 and 0.6 μg/cm2 nFe2O3-
exposed cells. Intracellular soluble ferric iron (Fe3+) levels were negligible across all 
treatments with no significant changes observed compared to the unexposed control (p > 
0.05; data not shown).
3.8 Iron transport protein expression analysis
Based on the observed enhanced ROS generation and intracellular iron content, we next 
assessed several key proteins associated with uptake (transferrin receptor, CD71; divalent 
metal ion transporter, DMT1), storage (ferritin, FTH1), and export of soluble iron 
(ferriportin, SLC40A1) in lung epithelial cells following acute and sub-chronic exposure to 
NMOs and MWCNTs [34,37]. Alterations to these proteins can impact loosely bound iron in 
the cytoplasm (i.e. labile iron pool), thus influencing redox reactions and ROS generation. 
Following acute 24 h exposure of each NMO to SAEC-hTERTs, CD71 displayed a 
significant 4-fold increase in expression at 0.0018 – 0.06 μg/cm2 delivered (Figure 5D), 
while higher doses caused no significant effect. Alternatively, DMT1 expression level did 
not significantly change under nCeO2 exposure, while moderate nFe2O3 doses resulted in 
significant elevation compared to unexposed cells (all χ2 = 7.4; p ≤ 0.05). Acute exposure to 
ENMs (0 – 0.18 μg/cm2 delivered) resulted in no significant change in FTH1 expression 
(Figure B.9). SLC40A1 exhibited relatively low expression level that did not significantly 
change following NMO exposure (all χ2 < 6.4, p > 0.05). These data suggested that NMO-
exposed SAEC-hTERTs experienced increased uptake of iron during acute exposure.
Lastly, we assessed prolonged changes in iron transport and storage ability in Fe2O3 and 
MWCNT transformed pSAECs. nFe2O3-transformed and nFe2O3 clones displayed a 
significant decrease in CD71 expression, while MWCNT clones displayed no significant 
change compared to low passage unexposed pSAECs (Figure 6A and D). Alternatively, 
transformed cells and clones exhibited a significant increase in DMT1 (Figure 6B and D). 
nFe2O3 cells possessed a 3.1-fold increase compared to control. Both nFe2O3 and MWCNT 
clones, however, exhibited a 14 to 17-fold increase compared to nFe2O3-transformed cells 
suggesting that over-expression of DMT1 is associated with a colony formation phenotype. 
Next, nFe2O3-transformed cells and clones displayed a significant 2-fold reduction in FTH1 
expression while no significant effect was observed in MWCNT clones compared to 
unexposed pSAECs (Figure 6C and D). Lastly, MWCNT clones displayed a significant 4-
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fold decrease in SLC40A1 expression while all other cell types did not differ from 
unexposed pSAECs.
To ascertain whether transformed Fe2O3- and MWCNT-exposed pSAECs exhibited 
enhanced ability to store intracellular iron, each sub-chronic cell type and isolated clones 
were assayed for intracellular iron compared to low passage, unexposed primary SAECs. 
Both transformed Fe2O3 and MWCNT-exposed cells possessed significantly elevated (2- to 
4-fold) Fe2+ content compared to controls and respective clones (Figure 6E; p ≤ 0.05). 
nFe2O3 and MWCNT clones exhibited a reduced, but still significantly elevated, levels of 
intracellular Fe2+ compared to controls. In addition, 11.4% of total intracellular iron in 
Fe2O3-transformed cells was Fe3+, which was not observed in any other acute or sub-
chronic exposed treatment group. Coupled with iron transport and storage protein expression 
data, these data suggested that sub-chronic exposure to ENMs with cell transformation 
ability results in increased ability to move divalent metal ions across cell membranes and 
lowered intracellular iron storage capacity in favor of an increased intracellular labile iron 
pool.
4. Discussion
Given that low concentration, chronic exposures are predicted from increased ENM 
production and use across their lifecycle), very few studies have evaluated ENMs for 
carcinogenic potential and no standardized testing framework exists, even as ENMs are 
quickly entering mass production and wide distribution [8,14, 56]. The current study 
evaluated the neoplastic transformation potential of two widely used NMOs, nCeO2 and 
nFe2O3, compared to an established ENM tumor promoter, MWCNT, in a human pSAEC 
model. To our knowledge, this study is the first to screen NMOs as complete carcinogens 
evidenced by neoplastic transformation potential following occupationally relevant exposure 
(0.18 μg/cm2) in a human lung epithelial cell model. Special emphasis was given to take into 
consideration the delivered doses to cells rather than the administered doses to be able to 
more accurately rank bioactivities across the various ENMs. We concluded that sub-chronic 
exposure to nFe2O3 for 10 weeks at a delivered dose of 0.180 μg/cm2 resulted in a 
neoplastic-like transformation and replicative immortalization of human pSAECs, similar to 
MWCNT, suggesting that occupational nFe2O3 exposure harbors risk for early neoplastic-
like transformation in the human lung.
Our continuous exposure method of treating cells every three days resulted in exposed 
pSAECs receiving 30–31% of the 0.6 μg/cm2 administered dose for both NMOs tested. 
Conversely, it is estimated that >90% of 0.06 μg/cm2 of MWCNT dispersed in albumin was 
delivered to exposed cells, based on their high aspect ratio, density, and hydrophobicity [57]. 
For simplicity we assumed that 100% of MWCNTs was delivered and that delivered and 
administered doses for MWCNTs was identical. Settling rates and eventual deposition of 
low aspect ratio nanoparticles onto attached in vitro cell models are determined by 
agglomerate size, effective density, sedimentation, diffusion, particle solubilization, and 
boundary layer absorption [47,49]. Both dispersed NMOs in SAGM medium exhibited 
similar hydrologic diameters and effective densities resulting in similar DG-modeled 
delivered mass, particle number, and surface area doses. Considering >90% of the 0.3 
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deposited NMO fractions occurred within the first 6–8 h for 6-well plates and 18–22 h in 96-
well plates, respectively, it appears that sedimentation onto the reflective boundary layer on 
the well bottom resulted in an upward diffusion gradient, then an equilibrium, thus 
minimizing further NMO deposition [49]. Since both NMOs exhibited similar delivered 
doses, the observed differences in pSAEC behavior and transformation can be attributed to 
their inherent physicochemical properties.
nCeO2 displayed enhanced proliferation ability, however, showed little evidence of 
aggressive neoplastic behavior. CeO2 valence states may contribute to cell proliferation 
(Ce4+) or inhibition (Ce3+) [58], in part due to its intra- and extracellular ROS sequestration 
ability [59]. In addition, a particle’s cellular fate and peroxide radical cycling ability may 
determine ROS-associated impacts on growth, survival, and disease development [28, 29, 
60, 61]. Here, increasing doses of nCeO2 reduced ROS levels thus suggesting nCeO2 acted 
as an anti-oxidant during the sub-chronic exposure. Several studies support our findings of 
ceria not promoting invasion or colony formation ability in malignant cells. Rather, it may 
act as an anti-cancer therapeutic [30] since it reduced promotion effects of known initiators 
and subsequent BALB/3T3 cell transformation in vitro [62]. Less reactive particles with 
moderate ROS generation or sequestration ability (e.g. ultrafine carbon black) typically 
show increased proliferation with low to moderate in vitro cell transformation ability 
compared to more reactive materials [10]. Past research studies showed that pulmonary 
exposure to cerium oxide resulted in no significant development of lung tumorigenesis. 
Single inhalation exposure to CeO2 resulted in 7 out of 1049 rats developing alveolar 
papillary neoplasms, adenocarcinoma, or carcinoma across their lifespan [31] that compared 
to unexposed animals. Given conflicting reports of the ability of ceria nanoparticles to 
generate ROS and cause DNA damage, the likelihood for potential neoplastic transformation 
may depend on particle fate, biopersistence, valence state, and persistent inflammation in 
exposed tissues.
Since the immortalized nFe2O3-transformed cells, nFe2O3 clones, MWCNT-transformed 
cells, and MWCNT clones showed increased survival ability (Figure 3C), moderate 
morphological transformation (Figure 3D), enhanced proliferation (Figure 4C), and 
acquisition/retention of soft agar colony forming ability (Figures 3B and 4D), the 
transformation can be interpreted as an early neoplastic phenotype [9, 63], since occasional 
Type II foci does not typify a malignant transformed cell [63]. MWCNTs (Mitsui #7) have a 
well-documented toxicological history in that they exhibit deep interstitial penetration, 
biopersistence, extrapulmonary transport, and promotion of lung adenocarcinoma and 
pleural mesothelioma [5, 41, 46] while in vitro studies with human SAECs (0.02 – 2.4 
μg/cm2) reported aneuploidy and neoplastic-like transformation [10, 11]. To date, most 
IONP in vitro toxicity studies have conducted acute, high dose exposures to evaluate 
genotoxicity, ROS production, proliferation, and cytotoxicity to model biomedical or dermal 
exposures [33, 64], including conflicting IONP cell transformation effects at high doses [65, 
66]. Collectively, nFe2O3 reportedly displayed a less potent effects than other IONPs 
[67,68]. Few studies have evaluated prolonged, low dose exposures to NMOs that possess 
high surface area, suspected genotoxic, and ROS-generating abilities, all known factors in 
tumorigenic initiation and promotion and are known effects following exposure to a 
complete carcinogen. Here, continuous exposure potentially caused prolonged ROS 
Stueckle et al. Page 15













generation resulting in accumulation of oxidative damage thus affecting cell proliferation 
and survival (i.e. 6 week data). The large gain and retention of proliferation rate well into 
post-exposure suggest that cells had switched from a damaged cell phenotype attempting to 
control ROS stress to a hyperplastic phenotype that potentially relied on particle-associated 
ROS generation. Numerous studies examining the effects of other soluble and micron-sized 
metals report similar phenomenon. Human bronchial epithelial cells were shown to switch 
from slowed, stressed phenotype to one that was highly proliferative and dependent on ROS 
signaling that promoted several cancer cell hallmarks [69].
At present conflicting reports on nFe2O3 toxicity following inhalation exposure exist on 
whether nFe2O3 exposure harbors significant pulmonary health risk. Sub-micron and 
micron-scaled Fe2O3 found in mild steel welding fumes typically does not result in lung 
tumorigenesis in chronically exposed welders [70], although this finding has been 
challenged [71]. Comparisons of pulmonary toxicity between nano-sized FeO, Fe2O3, and 
Fe3O4 found that nFe2O3 is relatively non-bioavailable (i.e. low free Fe ions) resulting in 
low toxicity compared to FeO and Fe3O4 [67]. Other recent in vivo reports suggest that 
respirable nFe2O3 caused alveolar wall damage, interstitium biopersistence, ROS-induced 
damage, inflammation, hemosiderin deposits, hyperplasia, and signs of fibrosis [6, 72, 73], 
with notable increased liver iron concentrations, inflammation, hyperemia, and hyperplasia. 
VENGES-generated nFe2O3 particles were shown to induce pulmonary tissue damage and 
inflammation following intratracheal (i.t.) exposure in rats [43], and elicited ROS generation 
in heart tissue following inhalation at 100–200 μg/m3 [44]. Given these reports of adverse 
outcomes commonly associated with early neoplasm development that align with this 
study’s findings, further research into nFe2O3 long-term pulmonary exposure to identify 
potential tumorigenic risk is needed.
Immortalization and neoplastic-like transformation of sub-chronic nFe2O3-exposed cells 
suggests disruption of iron homeostasis in the form of elevated labile ferrous iron pool, ROS 
generation, and elevated oxidative damage. Iron serves several critical roles in mammalian 
cells, however, excessive accumulation of iron in tissue is associated with numerous chronic 
pathologies, including cancer [34, 37, 74]. In biological systems, iron exists as Fe2+ or Fe3+ 
through gain or loss of electrons allowing for catalysis of oxygen species through the Fenton 
and Harbor-Weiss reactions leading to generation of ROS [34]. Thus, mammalian tissues are 
highly adapted to uptake, store, metabolize, and eliminate soluble and insoluble iron based 
on balancing physiological needs and toxicity resulting in iron homeostasis. Persistent iron 
overload or depletion is associated with numerous clinical pathologies including increased 
infection, cancer, anemia, and liver cirrhosis [34,37]. Here, nFe2O3 uptake into SAEC 
phagocytic vesicles and increased intracellular Fe2+ suggested that these particles 
experienced solubilization in acidic phagolysosomes and eventual release of Fe2+ into the 
cytoplasm to enter the cellular iron pool [33, 75]. IONPs experience either a cytoplasmic or 
phagolysosome fate which can depend on the particle’s size, surface charge, surface coating, 
and exposed cell/tissue type. Internalization of IONP particles within endosomes, 
lysosomes, or held in abiotic acidic conditions results in further oxidation and release of 
Fe2+ [75–77]. This potentially facilitated an increase in ROS in exposed SAECs by either 
interacting with the mitochondria membrane or catalyzing hydroxyl radical production via 
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hydrogen peroxide in acidic compartments [67, 68, 78]. In summary, it appears that IONPs’ 
intracellular fate determines its solubility and ROS generation ability.
Acute exposure studies with SAEC-hTERTs found that nFe2O3 exposure altered SAEC iron 
homeostasis evidenced by increased expression of two major import proteins (CD71 and 
DMT1), increased intracellular Fe2+, and ROS generation. In contrast, nCeO2 exposure 
experienced CD71 over-expression, no change in intracellular iron, and a modest ROS 
increase. Interestingly, a separate in vitro nCeO2 exposure (1 μg/cm2) caused differential 
expression of CD71 to BEAS-2B cells at 24 h post-exposure [79], possibly indicating that 
nCeO2 exposure may alter intracellular iron levels. For boundary layer epithelial cells 
between the external and internal environments, CD71 and DMT1 play important roles in 
iron uptake either through receptor-mediated endocytosis (i.e. CD71) or direct active 
transport across the membrane (DMT1). Iron in either phagolysosomes or CD71-containing 
endosomes solubilizes in the acidic environment, allowing for DMT1 to pump Fe2+ into the 
cytoplasm. In airway epithelium, FTH1 is found in the apical membrane to allow excess iron 
clearance via the mucociliary transport [34] and serves as the major intracellular storage 
protein to support the cytosolic labile iron pool with Fe2+ heavy chain and Fe3+ light chain 
storage. Although less is known about elimination, SLC40A1 plays an important role in 
pumping oxidized Fe3+ to the extracellular environment [74]. Normal epithelial cells exhibit 
relatively low CD71 and high ferriportin resulting in a small labile Fe pool [34]. Acute 
nFe2O3 exposure caused an increased ability to metabolize insoluble nFe2O3 resulting in a 
larger labile iron pool, with little evidence for altered elimination ability.
nFe2O3-transformed cells and clones displayed persistent over-expressed DMT1, decreased 
CD71 and FTH1, and increased intracellular iron compared to unexposed pSAECs 
suggesting that disruption of iron homeostasis over prolonged exposure shifted cells towards 
a larger labile iron pool and subsequent ROS generation. Similar findings, along with 
reduced SLC40A1 expression, in MWCNT clones suggests that persistent disruption of iron 
homeostasis may contribute to ENM-associated neoplastic-like transformation. Growing 
evidence supports the hypothesis that iron homeostasis disruption contributes to several 
cancer hallmarks, including genome stability, proliferation, energetics, and establishing the 
tumor microenvironment [37, 80]. Moreover, elevated iron levels and FTH1 expression [34] 
is a common observation following ultrafine iron or excessive particle inhalation exposure, 
iron overload in the lungs, and in cancer tissues. Elevated DMT1 or reduced CD71 
expression can assist lung cancer cell lines to partly rely on high levels of soluble iron that 
fuels ROS generation, iron-dependent proteins, and processes that help fuel accelerated 
tumor proliferation and metastasis [34,37]. Iron overload in the lung or liver typically results 
in DMT1 over-expression. Since DMT1 is responsible for uptake of non-transferrin bound 
iron, it is likely that aberrant over-expression contributed to elevated iron in nFe2O3-
tranformed cells. Moreover, it possibly contributed to soft agar colony formation ability in 
both nFe2O3 and MWCNT clones. Several proteins that are sensitive to ROS, iron levels, 
and are known tumor suppressor or enhancers possibly contributed to the observed changes 
in proteins involved in pSAEC iron transport. For example, p53 induction leads to increased 
FTH1 subunit and decreased CD71 expression [37, 74]. Our previous study identified over-
expressed MYC as key proto-oncogene in MWCNT neoplastic-like transformation in 
SAECs [10]. Enhanced MYC expression can block FTH1 expression by over-expressing 
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IRP2, a key transcriptional regulator of iron homeostasis and may contribute to DMT1 over-
expression [81]. Likewise, acute insoluble fiber exposure (e.g. asbestos) to human 
bronchoalveolar cells also showed elevated DMT1 and promotion of iron sequestration [34]. 
Next, many cancers exhibit a large labile iron pool due to suppressed FTH1 expression 
which appears to contribute to altered cell behavior, enhanced ROS, and tumorigenesis 
promotion [37]. In vitro exposure to dextran-coated γ-Fe2O3 nanoparticles caused increased 
levels of FTH1-stored iron and moderate ROS [82] while sub-chronic ferric ammonium 
citrate exposure, caused decreased in rat liver cell proliferation, soluble iron overload, and 
neoplastic transformation [83]. At present, our laboratory is currently conducting 
mechanistic time-response studies evaluating whether prolonged increases in labile iron 
contributes to increased and prolonged ROS switching cells from a oxidative damaged 
phenotype to a neoplastic-like phenotype.
With observed increased ROS, altered iron homeostasis in favor of excess intracellular Fe2+ 
iron, and cell immortalization, a growing literature base supports the hypothesis that long-
term IONP exposure results in clastogenic initiating events and elevated tumorigenesis risk 
[33, 64]. A recent CometChip screening platform conducted on a series of VENGES-
generated NMOs identified several metal oxide nanoparticles, including nFe2O3, harboring 
genotoxic potential [39]. Many in vitro exposure studies with different IONPs reported 
positive Comet assay, DNA damage products, and micronucleus frequency which associated 
with ROS induction [33, 38, 84, 85]. Conversely, other studies comparing Fe2O3 size-
dependent effects report little genotoxicity or cell transformation in several mammalian cell 
lines [77, 86]. A systematic genotoxicity screening of several IONP particles in human lung 
cells has been initiated in our laboratory.
Responsible nanotechnology development will require adequate tiered toxicity screening 
workflows for numerous EMNs using in vitro and in vivo models for human risk assessment 
to support ‘prevention by design’ ENMs [15]. Since a majority of ENM exposures of 
concern are likely chronic in nature, chronic exposure screening models are still in their 
infancy [56] and current in vitro murine and immortalized human cell transformation models 
possess caveats and assumptions with their use. An ideal human in vitro cell model would 
exhibit a wild type epithelial phenotype, chromosomal stability, minimal damage to tumor 
enhancer/suppressor genes, and the ability to culture cells for an extended period of time. 
Use of this ideal model in a neoplastic transformation testing strategy could help identify 
both genotoxic and non-genotoxic tumorigenic ENMs, an already accepted, relatively 
reliable, and fast carcinogen screening paradigm [87].
Here, the pSAEC model allowed us to a) screen particles against a known ENM tumor 
promotor and b) isolate and re-culture soft agar clones from nFe2O3 and MWCNT exposed 
pSAECs that retained a majority of the neoplastic-like phenotype. Isolation and 
characterization of attached or unattached clones displaying enhanced tumor-like properties 
allows for further mechanistic study of tumorigenesis phenomena. Recent studies with 
isolated colonies or spheroids have proven valuable by identifying bi or multinucleated cells 
(i.e. mitotic disruption and genetic instability), tumorspheres, holoclones with stem cell 
characteristics, cancer stem-like cells, and CNT-induced malignant transformed cells 
[88,89]. The only caveat with the pSAEC model is that unexposed or untransformed 
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passaged cells exhibit a finite survival time, thus making mechanistic studies requiring large 
cells numbers difficult. With further refinement by adding genotoxicity screening, our pilot 
study using human pSAECs as an in vitro complete carcinogen - cell transformation 
assessment model may provide a novel tool for high throughput screening of ENMs for 
tumorigenesis risk.
5. Conclusions
We propose that pSAEC cells may serve as an additional ENM Tier I tumorigenesis 
screening model for alternative screening methods for an ENM tiered risk assessment 
framework. This model identified a VENGES-generated nFe2O3 as possessing neoplastic-
like transformation ability, potentially through iron homeostasis disruption and elevated ROS 
levels, which were comparable to a MWCNT exposure, an established lung tumor promoter. 
The exposure model and use of sub-cultured clones can allow for screening and 
prioritization of numerous ENMs in shorter time spans (1 – 3 months) than traditional 
immortalized human cell transformation studies (4 – 6 months) and are not susceptible to 
issues with interspecies model comparisons. Further refinement of the proposed model to 
incorporate other cell types (e.g. macrophages) and acellular structure to simulate the tissue 
microenvironment will further enhance the predictability and accuracy of this sub-chronic in 
vitro model for ENM alternative testing strategies.
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FESEM field emission scanning electron microscope
hTERT human telomerase reverse transcriptase
IONP iron oxide nanoparticle
MWCNT multi-walled carbon nanotube
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nCeO2 nano-scaled cerium oxide
nFe2O3 nano-scaled ferric oxide
NIOSH National Institute for Occupational Safety and Health
NMO nanometal oxide
OSHA PEL Occupational Safety and Health Administration Permissible Exposure Limit
pSAEC primary small airway epithelial cell
RID Relevant In vitro Dosimetry
ROS reactive oxygen species
SAGM small airway cell growth medium
TEM transmission electron microscope
VCM Volumetric Centrifugation Method
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6. Appendices
Appendix A – Supplemental Methods. Figures B.1 – B.9.
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• This study investigated and compared bio-effects of long-term (10 weeks) in 
vitro exposure of nCeO2 and nFe2O3 vs. MWCNT in human primary small 
airway epithelial cells.
• Nanoparticle dosimetry and intracellular uptake were determined using 
distorted grid modeling, enhanced darkfield, and TEM microscopy.
• Sub-chronic exposure to nano-scaled metal oxides resulted in 30% deposition 
of the administered dose resulting in phagocytosis or cytoplasm fate.
• nFe2O3 and MWCNT caused increased proliferation, invasion, and colony 
formation indicating neoplastic-like transformation.
• Increased intracellular iron, ROS, and iron homeostasis disruption may be the 
mechanisms potentially contributing to cell transformation.
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Dosimetry modeling, cellular fate, and co-localization of nCeO2 and nFe2O3 particles via 
enhanced darkfield and transmission electron microscopy following exposure in primary 
human small airway epithelial cells. A) Harvard distorted grid modeling of sub-chronic 
exposure in 6-well plates (left) and acute exposure in 96-well plates (right). B) Cells plated 
on medium-conditioned glass slides were exposed for 48 h in 24-well plates to nCeO2 (left) 
and nFe2O3 (right; 0.017 μg/cm2 deposited). Both nanometal oxides were found co-
localized in cytoplasm. Bars = 10 μm. C) Following 24 h exposure to 0.18 μg/cm2, both 
nCeO2 and nFe2O3 were observed to undergo internalization via phagocytosis (black 
arrows) and the cell membrane periphery. D) nCeO2 was observed both in the cytoplasm 
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(white arrows) and enclosed in membrane-bound vesicles (black arrows). nFe2O3 particles 
were exclusively found in membrane-bound vesicles. ‘M’ signifies mitochondria. E) Both 
NMO were found as loose agglomerates within exposed cells. Bars = 400 nm.
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Cell morphology and cell proliferation of nCeO2, nFe2O3, and MWCNT-exposed pSAECs 
at 6 and 10 weeks after 0.18 μg NMO/cm2 and 0.06 μg MWCNT/cm2 exposures. A) At 48 h 
post-seeding, nCeO2, nFe2O3, and MWCNT exposed cells displayed a more rounded 
morphology compared to saline passage and low passage pSAECs. Bars and insert width = 
200 μm. B) At 6 weeks exposure, nCeO2-and MWCNT-exposed cells increased cell 
proliferation, as measured by WST-1 assay, above respective controls while nFe2O3-exposed 
cells experienced a significant reduction. C) At 10 weeks exposure, nFe2O3-exposed cells 
possessed the largest significant increase in cell proliferation compared to all treatments. D) 
Following 8 days recovery in particle-free medium, both nCeO2 and nFe2O3 retained 
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significantly elevated proliferation, while MWCNT-exposed cells exhibited a significant 
decrease compared to albumin-only (dispersant control) exposed cells. * and # indicate 
significant difference (p ≤ 0.05) compared to saline control and albumin-only exposed cells, 
respectively.
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Cell transformation evidenced by attachment independent and dependent colonies in 
nFe2O3- and MWCNT-exposed pSAECs. A) Representative micrographs of 6 and 10 week 
exposed cells to nCeO2, nFe2O3, and MWCNT compared to saline- and albumin-exposed 
(not shown) cells. B) Mean counts of colonies displaying attachment-independent growth in 
soft agar assay. Primary SAECs were exposed for 6 and 10 weeks, passaged, and then plated 
onto solidified agar supplemented with culture growth factors and 15% FBS. At Day 21, 
triplicate plates per population were counted and pooled. Numbers above 6 week mean 
counts indicate the total number of colonies observed over three replicates. C) nFe2O3 and 
MWCNT colony forming unit counts for 6 and 10 week transformed and soft agar clones. * 
indicates significant difference compared to saline and albumin passage controls (p < 0.05). 
D) Type I foci (black arrows) in nFe2O3- and MWCNT-exposed pSAECs at 6 week 
exposure. Scale bar = 5 mm. Small Type II foci in nFe2O3-exposed cells at 6 weeks 
surrounded by several bi-nucleated cells (white arrows; inset). Scale bar = 100 μm. 
Abnormal ‘giant cells’ were observed in MWCNT-exposed pSAECs. Scale bar = 100 μm. 
Small Type II focus in 10 week exposed nFe2O3 pSAECs (scale bar = 5 mm) and MWCNT 
pSAECs (scale bar = 100 μm).
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Subclones from 10 week nFe2O3 and MWCNT-exposed pSAEC soft agar colonies retained 
transformation and several cancer cell hallmark characteristics. A) Plated subclones 
exhibited foci in confluent plates. B) Multi-nucleated cells were observed in both sub-clone 
populations. C) Retention of accelerated proliferation compared to 10 week exposure 
populations, saline-(SAL), and albumin (ALB)-exposed cells, respectively. nFe2O3 10 week 
absorbance values exceeded detection values at 96 h time point. nFe2O3- and MWCNT-
exposed cells are compared to their respective vehicle control-exposed cells. Different * and 
# symbols indicate significant differences compared to other treatment groups at each time 
point. † indicates a significant decrease compared to ALB control (p ≤ 0.05). D) Both 
nFe2O3 and MWCNT clones exhibited significant increases (*, p < 0.05) in the number of 
soft agar colonies and E) significant decreases in invasion ability compared to their 10 week 
transformed counterparts, but above SAL-, and ALB-exposed cells’ ability. F) Enhanced 
apoptosis resistance of nFe2O3- and MWCNT-exposed cells in the extrinsic pathway 
compared to low passage pSAECs. Cells were exposed to FasL for 24 h, fluorescently 
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labeled, and imaged on the ImageXpress. Symbols indicate statistical significance from 
unexposed pSAEC (*), pSAEC (#) and all other treatment (+) (p < 0.05, n=4).
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ROS generation and iron homeostasis disruption in nFe2O3-exposed SAECs. A) Superoxide 
production at 1 h (Mitosox Red) and B) ROS levels (DCF) intensity quantification after 24 h 
exposure in pSAECs. C) Ferrous iron intracellular concentrations following acute 24 h 
exposure in SAEC-hTERT. D) Enhanced transferrin receptor (CD71) and divalent metal 
transporter 1 (DMT1) expression following 24 h acute exposure to nCeO2 and nFe2O3 in 
SAEC-hTERTs. MWCNT dosimetry was based off of data reported by Wang et al. 2010 and 
Nymark et al. 2014. * indicate a significant difference compared to unexposed and other 
exposed treatment groups (p<0.05).
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Altered iron homeostasis protein expression and increased intracellular iron levels in 
nFe2O3-transformed cells and colony clones. A) Decreased transferrin receptor (CD71) and 
B) increased divalent metal transporter (DMT1) expression in nFe2O3-transformed cells and 
clones compared to low passage, unexposed pSAECs. C) Decreased ferritin (FTH1) 
expression in nFe2O3-transformed cells and clones. D) Representative protein bands via 
SDS-page Western Blot. All densitometry quantification used GAPDH as a loading control. 
E) Increased intracellular ferrous iron in ENM sub-chronic exposed pSAECs. * indicate a 
significant difference compared to low passage pSAEC control (p<0.05).
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